Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.24
(
1.56%
)
Bitcoin
71,170.93
(
-0.10%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: investorgold2002 post# 120738

Monday, 05/30/2011 10:36:44 AM

Monday, May 30, 2011 10:36:44 AM

Post# of 257257

RLD claims average molecular weight range. Generic product in order to prove its equivalence will need to show their generic falls within the range of average mol weight as specified in RLD.

As noted in #msg-63695268, NVS/MNTA’s production process is not based on a predetermined* average molecular weight. This does not imply that the outcome of the process has an average molecular weight that differs from branded Copaxone.

*The word predetermined is highlighted with italicized text in NVS/MNTA’s legal pleadings.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now